REFERENCES
1. Chen X, Sun L, Mao Y, et al. Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancer.BMC Cancer . 2013;13:390.
2. Meattini I, Bicchierai G, Saieva C, et al. Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: Single-institution experience and review of published literature.Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol . 2017;43(4):642-648.
3. Tamaki K, Sasano H, Ishida T, et al. Comparison of core needle biopsy (CNB) and surgical specimens for accurate preoperative evaluation of ER, PgR and HER2 status of breast cancer patients. Cancer Sci . 2010;101(9):2074-2079.
4. Baco E, Rud E, Eri LM, et al. A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy. Eur Urol . 2016;69(1):149-156.
5. Hübner N, Shariat S, Remzi M. Prostate biopsy: guidelines and evidence. Curr Opin Urol . 2018;28(4):354-359.
6. Acord M, Shaikh R. Predictors of diagnostic success in image-guided pediatric soft-tissue biopsies. Pediatr Radiol . 2015;45(10):1529-1534.
7. Mitton B, Seeger LL, Eckardt MA, et al. Image-guided percutaneous core needle biopsy of musculoskeletal tumors in children. J Pediatr Hematol Oncol . 2014;36(5):337-341.
8. Hussain HK, Kingston JE, Domizio P, Norton AJ, Reznek RH. Imaging-guided core biopsy for the diagnosis of malignant tumors in pediatric patients. AJR Am J Roentgenol . 2001;176(1):43-47.
9. Garrett KM, Fuller CE, Santana VM, Shochat SJ, Hoffer FA. Percutaneous biopsy of pediatric solid tumors. Cancer . 2005;104(3):644-652.
10. Pohlig F, Kirchhoff C, Lenze U, et al. Percutaneous core needle biopsy versus open biopsy in diagnostics of bone and soft tissue sarcoma: a retrospective study. Eur J Med Res . 2012;17:29.
11. Weldon CB, Madenci AL, Tiao GM, et al. Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the children’s oncology group AHEP 0731 liver tumor committee. J Pediatr Surg . 2020;55(4):655-659.
12. Sung K-S, Seo S-W, Shon M-S. The diagnostic value of needle biopsy for musculoskeletal lesions. Int Orthop . 2009;33(6):1701-1706.
13. Blondiaux E, Laurent M, Audureau E, et al. Factors influencing the diagnostic yield and accuracy of image-guided percutaneous needle biopsy of pediatric tumors: single-center audit of a 26-year experience.Pediatr Radiol . 2016;46(3):372-382.
14. Hryhorczuk AL, Strouse PJ, Biermann JS. Accuracy of CT-guided percutaneous core needle biopsy for assessment of pediatric musculoskeletal lesions. Pediatr Radiol . 2011;41(7):848-857.
15. Willman JH, White K, Coffin CM. Pediatric Core Needle Biopsy: Strengths and Limitations in Evaluation of Masses. Pediatr Dev Pathol . 2001;4(1):46-52.
16. Campagna G, Rosenfeld E, Foster J, et al. Evolving biopsy techniques for the diagnosis of neuroblastoma in children. J Pediatr Surg . 2018;53(11):2235-2239.
17. Shin H-J, Amaral JG, Armstrong D, et al. Image-guided percutaneous biopsy of musculoskeletal lesions in children. Pediatr Radiol . 2007;37(4):362-369.
18. Ceraulo A, Ouziel A, Lavergne E, et al. Percutaneous guided biopsy for diagnosing suspected primary malignant bone tumors in pediatric patients: a safe, accurate, and cost-saving procedure. Pediatr Radiol . 2017;47(2):235-244.
19. Saarinen UM, Wikström S, Koskimies O, Sariola H. Percutaneous needle biopsy preceding preoperative chemotherapy in the management of massive renal tumors in children. J Clin Oncol Off J Am Soc Clin Oncol . 1991;9(3):406-415.
20. Wang H, Li F, Liu J, Zhang S. Ultrasound-guided core needle biopsy in diagnosis of abdominal and pelvic neoplasm in pediatric patients.Pediatr Surg Int . 2014;30(1):31-37.
21. Dykes EH, Marwaha RK, Dicks-Mireaux C, et al. Risks and benefits of percutaneous biopsy and primary chemotherapy in advanced Wilms’ tumour.J Pediatr Surg . 1991;26(5):610-612.
22. Ilivitzki A, Abugazala M, Arkovitz M, et al. Ultrasound-guided core biopsy as the primary tool for tissue diagnosis in pediatric oncology.J Pediatr Hematol Oncol . 2014;36(5):333-336.
23. Didolkar MM, Anderson ME, Hochman MG, et al. Image guided core needle biopsy of musculoskeletal lesions: are nondiagnostic results clinically useful? Clin Orthop . 2013;471(11):3601-3609.
24. Peer S, Freuis T, Loizides A, Gruber H. Ultrasound guided core needle biopsy of soft tissue tumors; a fool proof technique? Med Ultrason . 2011;13(3):187-194.
25. Noebauer-Huhmann I-M, Amann G, Krssak M, et al. Use of diagnostic dynamic contrast-enhanced (DCE)-MRI for targeting of soft tissue tumour biopsies at 3T: preliminary results. Eur Radiol . 2015;25(7):2041-2048.
26. Dupuy DE, Rosenberg AE, Punyaratabandhu T, Tan MH, Mankin HJ. Accuracy of CT-guided needle biopsy of musculoskeletal neoplasms.AJR Am J Roentgenol . 1998;171(3):759-762.
27. Overman RE, Kartal TT, Cunningham AJ, et al. Optimization of percutaneous biopsy for diagnosis and pretreatment risk assessment of neuroblastoma. Pediatr Blood Cancer . 2020;67(5).
28. Wang Z, Shi H, Zhang X, Pan J, Jin Z. Value of CT-guided percutaneous needle biopsy of bone in the diagnosis of lymphomas based on PET/CT results. Cancer Imaging Off Publ Int Cancer Imaging Soc . 2019;19(1):42.
29. Wu M, Xiao L, Liu H, et al. PET/CT-guided versus CT-guided percutaneous core biopsies in the diagnosis of bone tumors and tumor-like lesions: which is the better choice? Cancer Imaging . 2019;19(1):69.
30. Taupin T, Decouvelaere A-V, Vaz G, Thiesse P. Accuracy of core needle biopsy for the diagnosis of osteosarcoma: A retrospective analysis of 73patients. Diagn Interv Imaging . 2016;97(3):327-331.
31. Loizides A, Widmann G, Freuis T, Peer S, Gruber H. Optimizing ultrasound-guided biopsy of musculoskeletal masses by application of an ultrasound contrast agent. Ultraschall Med Stuttg Ger 1980 . 2011;32(3):307-310.
32. Bettati P, Chalian M, Huang J, Dormer JD, Shahedi M, Fei B. Augmented Reality-Assisted Biopsy of Soft Tissue Lesions. Proc SPIE– Int Soc Opt Eng . 2020;11315.
33. Ambros PF, Ambros IM, Brodeur GM, et al. International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer . 2009;100(9):1471-1482.
34. Lodrini M, Sprüssel A, Astrahantseff K, et al. Using droplet digital PCR to analyze MYCN and ALK copy number in plasma from patients with neuroblastoma. Oncotarget . 2017;8(49):85234-85251.
35. Somasundaram DB, Aravindan S, Yu Z, et al. Droplet digital PCR as an alternative to FISH for MYCN amplification detection in human neuroblastoma FFPE samples. BMC Cancer . 2019;19(1):106.
36. Steliarova-Foucher E, Fidler MM, Colombet M, et al. Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991-2010 (Automated Childhood Cancer Information System): a population-based study. Lancet Oncol . 2018;19(9):1159-1169.
37. Nakata K, Ito Y, Magadi W, et al. Childhood cancer incidence and survival in Japan and England: A population-based study (1993-2010).Cancer Sci . 2018;109(2):422-434.
38. Park HJ, Moon E-K, Yoon JY, et al. Incidence and Survival of Childhood Cancer in Korea. Cancer Res Treat Off J Korean Cancer Assoc . 2016;48(3):869-882.
39. Tulla M, Berthold F, Graf N, et al. Incidence, Trends, and Survival of Children With Embryonal Tumors. Pediatrics . 2015;136(3):e623-632.
40. Shinagawa T, Kitamura T, Katanoda K, Matsuda T, Ito Y, Sobue T. The incidence and mortality rates of neuroblastoma cases before and after the cessation of the mass screening program in Japan: A descriptive study. Int J Cancer . 2017;140(3):618-625.
41. Allen-Rhoades W, Whittle SB, Rainusso N. Pediatric Solid Tumors of Infancy: An Overview. Pediatr Rev . 2018;39(2):57-67.
LEGENDS
Figure 1 Flowchart of patient selection